AstraZeneca Share Holder Equity 2010-2024 | AZN

AstraZeneca share holder equity for the quarter ending September 30, 2024 was $40.805B, a 9.63% increase year-over-year.

  • AstraZeneca share holder equity for 2023 was $39.166B, a 5.69% increase from 2022.
  • AstraZeneca share holder equity for 2022 was $37.058B, a 5.67% decline from 2021.
  • AstraZeneca share holder equity for 2021 was $39.287B, a 151.23% increase from 2020.

AstraZeneca Share Holder Equity 2010-2024 | AZN

  • AstraZeneca share holder equity for 2023 was $39.166B, a 5.69% increase from 2022.
  • AstraZeneca share holder equity for 2022 was $37.058B, a 5.67% decline from 2021.
  • AstraZeneca share holder equity for 2021 was $39.287B, a 151.23% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B